Jolyon P Mitchell1, Ariel Berlinski2, Sebastian Canisius3, David Cipolla4, Myrna B Dolovich5, Igor Gonda6, Guenther Hochhaus7, Nani Kadrichu8, Svetlana Lyapustina9, Heidi M Mansour10, Chantal Darquenne11, Andy R Clark12, Michael Newhouse13,14, Stephan Ehrmann15, Robert Humphries16, Homer Boushey17. 1. Jolyon Mitchell Inhaler Consultancy Services, Inc., London, Ontario, Canada. 2. Pulmonology Division, Department of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock, Arkansas, USA. 3. ACLiRA Consulting GmbH, Ebsdorfergrund, Germany. 4. Insmed, Inc., Bridgewater, New Jersey, USA. 5. Department of Medicine, McMaster University, Hamilton, Ontario, Canada. 6. Respidex LLC, Dennis, Massachusetts, USA. 7. College of Pharmacy, University of Florida, Gainesville, Florida, USA. 8. Inspired-Pulmonary Solutions LLC, San Carlos, California, USA. 9. Faegre Drinker Biddle & Reath LLP, Washington, District of Columbia, USA. 10. College of Pharmacy, College of Medicine and The University of Arizona-Tucson, Tucson, Arizona, USA. 11. Department of Medicine, UCSD, La Jolla, California, USA. 12. Aerogen Pharma Corporation, San Mateo, California, USA. 13. St. Joseph's Hospital Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. 14. Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario, Canada. 15. Centre Hospitalier Régional et Universitaire de Tours, Médecine Intensive Réanimation, Tours, France. 16. VisionRealisation, Shepshed, Leicestershire, United Kingdom. 17. School of Medicine, Universtiy of California San Francisco, San Francisco, California, USA.
Authors: Janusz Marcinkiewicz; Markus Nagl; Anthony Kyriakopoulos; Maria Walczewska; Magdalena Skóra; Paulina Skalska Journal: Adv Exp Med Biol Date: 2022 Impact factor: 3.650
Authors: Ahmed A H Abdellatif; Hesham M Tawfeek; Ahmed Abdelfattah; Gaber El-Saber Batiha; Helal F Hetta Journal: J Drug Deliv Sci Technol Date: 2021-02-19 Impact factor: 3.981